Literature DB >> 27121545

Telephone based cognitive-behavioral screening for frontotemporal changes in patients with amyotrophic lateral sclerosis (ALS).

Georgia Christodoulou1, Chris Gennings2, Jonathan Hupf1, Pam Factor-Litvak3, Jennifer Murphy4, Raymond R Goetz5, Hiroshi Mitsumoto1.   

Abstract

Our objective was to establish a valid and reliable battery of measures to evaluate frontotemporal dementia (FTD) in patients with ALS over the telephone. Thirty-one subjects were administered either in-person or by telephone-based screening followed by the opposite mode of testing two weeks later, using a modified version of the UCSF Cognitive Screening Battery. Equivalence testing was performed for in-person and telephone based tests. The standard ALS Cognitive Behavioral Screen (ALS-CBS) showed statistical equivalence at the 5% significance level compared to a revised phone version of the ALS-CBS. In addition, the Controlled Oral Word Association Test (COWAT) and Center for Neurologic Study-Lability Scale (CNS-LS) were also found to be equivalent at the 5% and 10% significance level, respectively. Similarly, the Mini-Mental State Examination (MMSE) and the well-established Telephone Interview for Cognitive Status (TICS) were also statistically equivalent. Equivalence could not be claimed for the ALS-Frontal Behavioral Inventory (ALS-FBI) caregiver interview and the Written Verbal Fluency Index (WVFI). In conclusion, our study suggests that telephone-based versions of the ALS-CBS, COWAT, and CNS-LS may offer clinicians valid tools to detect frontotemporal changes in the ALS population. Development of telephone based cognitive testing for ALS could become an integral resource for population based research in the future.

Entities:  

Keywords:  ALS; FTD; cognitive testing; telephone

Mesh:

Year:  2016        PMID: 27121545      PMCID: PMC5356507          DOI: 10.3109/21678421.2016.1173703

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  29 in total

Review 1.  Understanding equivalence and noninferiority testing.

Authors:  Esteban Walker; Amy S Nowacki
Journal:  J Gen Intern Med       Date:  2010-09-21       Impact factor: 5.128

2.  Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS).

Authors:  Susan C Woolley; Michele K York; Dan H Moore; Adriana M Strutt; Jennifer Murphy; Paul E Schulz; Jonathan S Katz
Journal:  Amyotroph Lateral Scler       Date:  2010-05-03

3.  Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS).

Authors:  S Abrahams; P N Leigh; A Harvey; G N Vythelingum; D Grisé; L H Goldstein
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

Review 4.  Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis.

Authors:  Jennifer Murphy; Roland Henry; Catherine Lomen-Hoerth
Journal:  Arch Neurol       Date:  2007-03

Review 5.  FTD and ALS: a tale of two diseases.

Authors:  R Ferrari; D Kapogiannis; E D Huey; P Momeni
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

Review 6.  A critical review of the use of telephone tests to identify cognitive impairment in epidemiology and clinical research.

Authors:  Marie Herr; Joël Ankri
Journal:  J Telemed Telecare       Date:  2013-02-06       Impact factor: 6.184

7.  The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS.

Authors:  Jennifer Murphy; Fizaa Ahmed; Catherine Lomen-Hoerth
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-10       Impact factor: 4.092

Review 8.  Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments.

Authors:  Teresa C Castanho; Liliana Amorim; Joseph Zihl; Joana A Palha; Nuno Sousa; Nadine C Santos
Journal:  Front Aging Neurosci       Date:  2014-02-25       Impact factor: 5.750

9.  C9orf72 repeat expansions are restricted to the ALS-FTD spectrum.

Authors:  Nicola Ticozzi; Cinzia Tiloca; Daniela Calini; Stella Gagliardi; Alessandra Altieri; Claudia Colombrita; Cristina Cereda; Antonia Ratti; Gianni Pezzoli; Barbara Borroni; Stefano Goldwurm; Alessandro Padovani; Vincenzo Silani
Journal:  Neurobiol Aging       Date:  2013-10-02       Impact factor: 4.673

10.  Screening for cognition and behaviour changes in ALS.

Authors:  Sharon Abrahams; Judith Newton; Elaine Niven; Jennifer Foley; Thomas H Bak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-06-19       Impact factor: 4.092

View more
  11 in total

1.  Disease progression in C9orf72 mutation carriers.

Authors:  Mary K Floeter; Bryan J Traynor; Jennifer Farren; Laura E Braun; Michael Tierney; Edythe A Wiggs; Tianxia Wu
Journal:  Neurology       Date:  2017-06-14       Impact factor: 9.910

2.  ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability.

Authors:  Lucio Tremolizzo; Andrea Lizio; Gabriella Santangelo; Susanna Diamanti; Christian Lunetta; Francesca Gerardi; Sonia Messina; Stefania La Foresta; Nilo Riva; Yuri Falzone; Massimo Filippi; Susan C Woolley; Valeria Ada Sansone; Mattia Siciliano; Carlo Ferrarese; Ildebrando Appollonio
Journal:  Neurol Sci       Date:  2019-12-05       Impact factor: 3.307

3.  Preliminary Findings from a Telephone-Based Cognitive Screening of an Adult HIV Research Cohort during the COVID-19 Pandemic.

Authors:  Jairo A Gonzalez; Uraina S Clark; Desiree Byrd; Yusuf Clarke; Kaitlyn Greenwood; Elizabeth Tell; Cira Carrion-Park; Maria Pizzirusso; Rhonda Burgess; Susan Morgello
Journal:  Arch Clin Neuropsychol       Date:  2022-07-02       Impact factor: 3.448

Review 4.  Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia.

Authors:  Lucy C Beishon; Emma Elliott; Tuuli M Hietamies; Riona Mc Ardle; Aoife O'Mahony; Amy R Elliott; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2022-04-08

Review 5.  Psychometric Properties of Cognitive Assessment in Amyotrophic Lateral Sclerosis: A Systematic Review.

Authors:  Tina Taule; Margaret Søvik; Regina Küfner Lein; Eike Wehling; Jörg Aßmus; Tiina Rekand
Journal:  Patient Relat Outcome Meas       Date:  2020-09-22

6.  Telephone-based Frontal Assessment Battery (t-FAB): standardization for the Italian population and clinical usability in neurological diseases.

Authors:  Edoardo Nicolò Aiello; Veronica Pucci; Lorenzo Diana; Aida Niang; Alice Naomi Preti; Adriana Delli Ponti; Gaia Sangalli; Stefano Scarano; Luigi Tesio; Stefano Zago; Teresa Difonzo; Ildebrando Appollonio; Sara Mondini; Nadia Bolognini
Journal:  Aging Clin Exp Res       Date:  2022-06-14       Impact factor: 4.481

7.  Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis.

Authors:  Meredith Bock; Y-Nhy Duong; Anthony Kim; Isabel Allen; Jennifer Murphy; Catherine Lomen-Hoerth
Journal:  Neurol Clin Pract       Date:  2017-12

8.  A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival.

Authors:  Tom Burke; Marta Pinto-Grau; Katie Lonergan; Peter Bede; Meabhdh O'Sullivan; Mark Heverin; Alice Vajda; Russell L McLaughlin; Niall Pender; Orla Hardiman
Journal:  Ann Clin Transl Neurol       Date:  2017-04-11       Impact factor: 4.511

Review 9.  Tele-neuropsychological assessment tools in Italy: a systematic review on psychometric properties and usability.

Authors:  Elia Zanin; Edoardo Nicolò Aiello; Lorenzo Diana; Giulia Fusi; Mario Bonato; Aida Niang; Francesca Ognibene; Alessia Corvaglia; Carmen De Caro; Simona Cintoli; Giulia Marchetti; Alec Vestri
Journal:  Neurol Sci       Date:  2021-11-09       Impact factor: 3.830

Review 10.  Cognitive Assessment via Telephone: A Scoping Review of Instruments.

Authors:  Anne R Carlew; Hudaisa Fatima; Julia R Livingstone; Caitlin Reese; Laura Lacritz; Cody Pendergrass; Kenneth Chase Bailey; Chase Presley; Ben Mokhtari; Colin Munro Cullum
Journal:  Arch Clin Neuropsychol       Date:  2020-11-19       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.